EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils

Wolfgang E Reintsch, Andrea I Krahn, Chanshuai Han, Emmanuelle Nguyen-Renou, Carol X-Q Chen, Wen Luo, Irina Shlaifer, Tom Pfeifer, Edward A Fon, Thomas M Durcan

Methods · 2026-08 · 252 · 41-54

DOI: 10.1016/j.ymeth.2026.05.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods, 2026-08. Verfasst von Wolfgang E Reintsch und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Neuro's Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada. Hauptthemen laut MEDLINE: alpha-Synuclein, Dopaminergic Neurons, High-Throughput Screening Assays, Parkinson Disease. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canada Research Chairs Program, Canadian Consortium on Neurodegeneration in Aging, Canada First Research Excellence Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinDopaminergic NeuronsHigh-Throughput Screening AssaysParkinson DiseaseProtein Aggregation, PathologicalSmall Molecule LibrariesHumansInduced Pluripotent Stem CellsProtein AggregatesLewy Bodies

Stichwörter der Autor:innen

Dopaminergic neuronsHigh content screeningHuman induced pluripotent stem cellsPFF uptakeParkinsonα-Synuclein preformed fibrils (PFF)

Substanzen

alpha-SynucleinProtein AggregatesSmall Molecule Libraries

Autor:innen und Institutionen

  • The Neuro's Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada.
  • Biofactorial High Throughput Biology Facility, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
  • Neurodegenerative Disorders Research Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada.
  • The Neuro's Early Drug Discovery Unit (EDDU), McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada. Electronic address: thomas.durcan@mcgill.ca.

Förderung

  • Canada Research Chairs Program
  • Canadian Consortium on Neurodegeneration in Aging
  • Canada First Research Excellence Fund
  • Canadian Institutes of Health Research
  • Government of Canada
  • CQDM
  • McGill University
  • The Michael J Fox Foundation for Parkinson's Research

Zitieren

APA

Reintsch, W. E., Krahn, A. I., Han, C., Nguyen-Renou, E., Chen, C. X., Luo, W., Shlaifer, I., Pfeifer, T., Fon, E. A., & Durcan, T. M. (2026). A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils. Methods, 252, 41-54. https://doi.org/10.1016/j.ymeth.2026.05.001

Vancouver

Reintsch WE, Krahn AI, Han C, Nguyen-Renou E, Chen CX, Luo W, et al. A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils. Methods. 2026;252:41-54. doi:10.1016/j.ymeth.2026.05.001

BibTeX
@article{Reintsch2026,
  author = {Reintsch, Wolfgang E and Krahn, Andrea I and Han, Chanshuai and Nguyen-Renou, Emmanuelle and Chen, Carol X-Q and Luo, Wen and Shlaifer, Irina and Pfeifer, Tom and Fon, Edward A and Durcan, Thomas M},
  title = {A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils},
  journal = {Methods},
  year = {2026},
  volume = {252},
  pages = {41--54},
  doi = {10.1016/j.ymeth.2026.05.001}
}
Kostenlos starten →